XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Unaudited Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 10,775 $ 10,439 $ 29,307 $ 30,173
Operating expenses:        
Costs of revenue 4,341 4,783 12,224 14,217
Selling, general and administrative expenses 9,202 7,306 27,104 20,787
Research and development expenses 1,018 507 2,403 1,610
Total operating expenses 14,561 12,596 41,731 36,614
Loss from operations (3,786) (2,157) (12,424) (6,441)
Interest expense (647) (909) (1,913) (2,720)
Change in fair value of financial instruments 0 (200) 0 267
Other income, net 125 125 985 264
Loss before income taxes (4,308) (3,141) (13,352) (8,630)
Income tax benefit 0 0 118 0
Net loss (4,308) (3,141) (13,234) (8,630)
Accretion of redeemable convertible preferred stock 0 (338) 0 (4,640)
Deemed dividend recorded in connection with financing transactions 0 (13,601) 0 (13,601)
Net loss attributable to common stockholders (Note 2) $ (4,308) $ (17,080) $ (13,234) $ (26,871)
Net loss per share, basic and diluted (USD per share) $ (0.34) $ (11.29) $ (1.05) $ (48.70)
Weighted-average number of shares used to compute net loss per share, basic and diluted (in shares) 12,644,348 1,513,189 12,626,259 551,730